{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:58:22Z","timestamp":1772791102963,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11530-6","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:58:39Z","timestamp":1772780319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression patterns of ANRIL and GAS-5 and genetic variants in breast cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Ibrahim T.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Kandeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"2","key":"11530_CR1","first-page":"101","volume":"19","author":"O Shaker","year":"2023","unstructured":"Shaker O, Mohammed NA (2023) Chitinase 3-like protein1 (YKL-40) as a biomarker in serum of Egyptian breast cancer females. Int J Cancer Res 19(2):101\u2013112","journal-title":"Int J Cancer Res"},{"issue":"2","key":"11530_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.gene.2016.01.042","volume":"590","author":"TM Motawi","year":"2016","unstructured":"Motawi TM, Sadik NA, Shaker OG, Masry E, M. R., Mohareb F (2016) Study of microRNAs-21\/221 as potential breast cancer biomarkers in Egyptian women. Gene 590(2):210\u2013219","journal-title":"Gene"},{"issue":"17","key":"11530_CR3","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A (2021) Breast Cancer-Epidemiology, risk Factors, Classification, prognostic Markers, and current treatment Strategies-An updated review. Cancers 13(17):4287","journal-title":"Cancers"},{"issue":"1","key":"11530_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, Huang L, Liu CC, Shao ZM, Yu KD (2025) Breast cancer: pathogenesis and treatments. Signal Transduct Target Therapy 10(1):49","journal-title":"Signal Transduct Target Therapy"},{"issue":"10","key":"11530_CR5","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1002\/jcp.29546","volume":"235","author":"K Zhang","year":"2020","unstructured":"Zhang K, Luo Z, Zhang Y, Song X, Han L, Yuan R (2020) The role of long non-coding RNAs in breast cancer. J Cell Physiol 235(10):7016\u20137027","journal-title":"J Cell Physiol"},{"issue":"5","key":"11530_CR6","first-page":"1031","volume":"16","author":"O Shaker","year":"2020","unstructured":"Shaker O, Mahmoud RH, Abdelhamid AH (2020) Long non-coding RNAs as a novel biomarker in breast cancer: mechanistic insights and clinical implications. J Cancer Res Ther 16(5):1031\u20131038","journal-title":"J Cancer Res Ther"},{"issue":"16","key":"11530_CR7","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.3390\/cancers15164160","volume":"15","author":"A Sanchez","year":"2023","unstructured":"Sanchez A, Lhuillier J, Grosjean G, Ayadi L, Maenner S (2023) The long Non-Coding RNA ANRIL in cancers. Cancers 15(16):4160","journal-title":"Cancers"},{"issue":"2","key":"11530_CR8","first-page":"140","volume":"22","author":"AM Al-Khaleel","year":"2023","unstructured":"Al-Khaleel AM, Al-Azzawi MA (2023) The role of long non-coding RNA ANRIL gene expression and serum Interleukin-27 levels in breast cancer patients. Iraqi J Biotechnol 22(2):140\u2013152","journal-title":"Iraqi J Biotechnol"},{"key":"11530_CR9","volume":"224","author":"X Zhang","year":"2021","unstructured":"Zhang X, Gao L, Li H, Ye Y (2021) LncRNA polymorphisms and breast cancer risk. Pathol Res Pract 224:153511","journal-title":"Pathol Res Pract"},{"key":"11530_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.710538","volume":"11","author":"C Lu","year":"2021","unstructured":"Lu C, Wei D, Zhang Y, Wang P, Zhang W (2021) Long non-coding RNAs as potential diagnostic and prognostic biomarkers in breast cancer: progress and prospects. Front Oncol 11:710538","journal-title":"Front Oncol"},{"issue":"5","key":"11530_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jmoldx.2018.05.002","volume":"20","author":"S Asghar","year":"2018","unstructured":"Asghar S, Ashraf N, Jabeen S, Tariq M (2018) Expression analysis of MALAT1, GAS5, SRA, and NEAT1 lncRNAs in breast cancer. J Mol Diagn 20(5):635\u2013647","journal-title":"J Mol Diagn"},{"issue":"3","key":"11530_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna5030046","volume":"5","author":"AS Goustin","year":"2019","unstructured":"Goustin AS, Thepsuwan P, Kosir MA, Lipovich L (2019) The growth-arrest-specific (GAS)-5 long non-coding RNA: a fascinating lncRNA widely expressed in cancers. Non-coding RNA 5(3):46","journal-title":"Non-coding RNA"},{"issue":"16","key":"11530_CR13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164160","volume":"15","author":"A S\u00e1nchez","year":"2023","unstructured":"S\u00e1nchez A (2023) ANRIL: a long noncoding RNA at the CDKN2A\/B locus with roles in cancer and metabolic disease. Cancers 15(16):4160","journal-title":"Cancers"},{"issue":"1","key":"11530_CR14","first-page":"22","volume":"2","author":"B \u00c1lvarez-Reyes","year":"2020","unstructured":"\u00c1lvarez-Reyes B, Barrera-Tamariz MR, Contreras-G\u00f3mora I, Mungu\u00eda-Arriaga MA, \u00c1vila-Avil\u00e9s RD (2020) Relationship of long non-coding RNA to breast cancer. J Cancer Immunol 2(1):22\u201334","journal-title":"J Cancer Immunol"},{"key":"11530_CR15","volume":"17","author":"A Eisa","year":"2025","unstructured":"Eisa A, Yousif S, AboAlella MA, Awad S, Yousif H, Dafaalla T (2025) The multifaceted role of lncRNA GAS5: a pan-cancer analysis of its diagnostic, prognostic, and therapeutic potential. Cureus 17:333212","journal-title":"Cureus"},{"key":"11530_CR16","unstructured":"QIAGEN (2026) QIAamp DNA Kits. QIAGEN. https:\/\/www.qiagen.com\/as\/products\/discovery-and-translational-research\/dna-rna-purification\/dna-purification\/genomic-dna\/qiaamp-dna-kits"},{"key":"11530_CR17","doi-asserted-by":"crossref","unstructured":"Epigenetic (2025) regulation by lncRNA GAS5\/miRNA\/mRNA network in human diseases. International Journal of Molecular Sciences, 26(3), 1377","DOI":"10.3390\/ijms26031377"},{"key":"11530_CR18","first-page":"44981","volume":"16","author":"J Ji","year":"2024","unstructured":"Ji J, Dai X, Yeung SJJ, He X (2024) The role of long non-coding RNA GAS5 in cancers [Review]. Cancer Manag Res 16:44981\u201344993","journal-title":"Cancer Manag Res"},{"key":"11530_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s43994-024-00153-x","volume":"11","author":"IZ Sadiq","year":"2025","unstructured":"Sadiq IZ, Usman A, Muhammad A, Ahmad KH (2025) Sample size calculation in biomedical, clinical and biological sciences research. J Umm Al-Qura Univ Appl Sci 11:133\u2013141","journal-title":"J Umm Al-Qura Univ Appl Sci"},{"issue":"7","key":"11530_CR20","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","volume":"25","author":"AE Giuliano","year":"2018","unstructured":"Giuliano AE, Edge SB, Hortobagyi GN (2018) Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol 25(7):1783\u20131785","journal-title":"Ann Surg Oncol"},{"key":"11530_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00885","volume":"9","author":"PM Mehta-Mujoo","year":"2019","unstructured":"Mehta-Mujoo PM, Cunliffe HE, Hung NA, Slatter TL (2019) Long non-coding RNA ANRIL in the nucleus associates with periostin expression in breast cancer. Front Oncol 9:885","journal-title":"Front Oncol"},{"issue":"7","key":"11530_CR22","first-page":"1053","volume":"32","author":"DAA Mohammed","year":"2025","unstructured":"Mohammed DAA, Elzawawy AM, Abdallah HY, Abdel Salam LOF, Shafik HE, Atef MM (2025) Correlation between three long non\u2011coding RNA gene expression and pathological response in breast cancer patients receiving neoadjuvant chemotherapy in Egypt. Journal of Population Therapeutics and Clinical Pharmacology 32(7):1053\u20131061","journal-title":"Journal of Population Therapeutics and Clinical Pharmacology"},{"issue":"1","key":"11530_CR23","first-page":"1","volume":"27","author":"Z Haghshenas","year":"2025","unstructured":"Haghshenas Z, Mozdarani H (2025) Differential expression of long non-coding RNAs MALAT1, ANRIL and MEG3 in radiation-exposed breast cancer. Cell J 27(1):1\u201310","journal-title":"Cell J"},{"key":"11530_CR24","volume":"308","author":"Z Wu","year":"2022","unstructured":"Wu Z, Liu X (2022) Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer by sponging miR-199a. Life Sci 308:120937","journal-title":"Life Sci"},{"issue":"3","key":"11530_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/jir.2018.0117","volume":"39","author":"OG Shaker","year":"2019","unstructured":"Shaker OG, Mahmoud RH, Abdelaleem OO, Ahmed TI, Fouad NA, Hussein HA, Nassr MH, Zaki OM, Abdelghaffar NK, Hefzy EM (2019) Expression profile of long noncoding RNAs, lnc-Cox2, and HOTAIR in rheumatoid arthritis patients. J Interferon Cytokine Res 39(3):174\u2013180","journal-title":"J Interferon Cytokine Res"},{"key":"11530_CR26","first-page":"215","volume":"561","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang J, Xu L (2025) Long non-coding RNA GAS5 as a tumor suppressor in breast cancer: mechanisms and therapeutic implications. Cancer Lett 561:215\u2013227","journal-title":"Cancer Lett"},{"issue":"1","key":"11530_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/hmbci-2022-0027","volume":"44","author":"X Zhang","year":"2023","unstructured":"Zhang X, Li D (2023) GAS5 regulated by FTO-mediated m6A modification suppresses cell proliferation via the IGF2BP2\/QKI axis in breast cancer. Horm Mol Biol Clin Investig 44(1):45\u201356","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"13","key":"11530_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136810","volume":"22","author":"EA Filippova","year":"2021","unstructured":"Filippova EA, Fridman MV, Burdennyy AM, Loginov VI, Pronina IV, Lukina SS, Dmitriev AA, Braga EA (2021) Long noncoding RNA GAS5 in breast cancer: epigenetic mechanisms and biological functions. Int J Mol Sci 22(13):6810","journal-title":"Int J Mol Sci"},{"issue":"11","key":"11530_CR29","first-page":"4873","volume":"23","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Liu T, Ma Y, Zhang X, Huang C (2019) LncRNA GAS5 affects epithelial-mesenchymal transition and invasion of breast cancer by regulating miR-216b. Eur Rev Med Pharmacol Sci 23(11):4873\u20134881","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11530_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03006-z","volume":"16","author":"N Kumud","year":"2025","unstructured":"Kumud N, Verma Y, Kulshrestha MR, Singh A, Sanyal S (2025) Single nucleotide polymorphism and expression of p16 gene as a potential biomarker for oral and pre-oral cancer. Discov Oncol 16:1229","journal-title":"Discov Oncol"},{"issue":"3","key":"11530_CR31","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1016\/j.clbc.2018.11.006","volume":"19","author":"Y Tang","year":"2019","unstructured":"Tang Y, Wang Y, Wang X, Liu Y, Zheng K (2019) A genetic variant of rs145204276 in the promoter region of long noncoding RNA GAS5 is associated with a reduced risk of breast cancer. Clin Breast Cancer 19(3):e415\u2013e421","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"11530_CR32","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.31557\/APJCP.2020.21.12.3705","volume":"21","author":"R Sharifi","year":"2020","unstructured":"Sharifi R, Shahangian SS, Salehi Z, Mashayekhi F, Talesh Sasani S, Mirzanezhad L (2020) Influence of a 5-bp indel polymorphism at promoter of the GAS5 lncRNA and risk of breast cancer. Asian Pac J Cancer Prev 21(12):3705\u20133710","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11530-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11530-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11530-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:58:52Z","timestamp":1772780332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11530-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11530"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11530-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The content has not been published, nor has submitted for publication elsewhere.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The study protocol was approved by the Faculty of Medicine, Cairo University with approval code REC-H-phBSU-24016 on 24\/09\/2024.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare that there is no conflict of interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"466"}}